結果 : OncLiveTV
10:54

Gilteritinib for FLT3-Mutant AML

OncLiveTV
1,873 回視聴 - 5 年前
1:02

Dr. Wenham on Rationale for Novel Immunotherapy Combos in Ovarian Cancer

OncLive
1,384 回視聴 - 3 年前
7:19

Follicular Lymphoma: Defining Copanlisib’s Value

OncLive
661 回視聴 - 6 年前

-
1:28

Dr. Formenti on Benefits of Combining Radiotherapy with Immunotherapy in NSCLC

OncLive
384 回視聴 - 8 年前
2:16

Dr. Rini on Axitinib for Treatment of Metastatic Renal Cell Carcinoma

OncLiveTV
1,972 回視聴 - 8 年前
7:48

The Current Understanding of Biomarkers in Melanoma

OncLiveTV
673 回視聴 - 7 年前
56:56

Metastatic CRC Nursing Webinar

OncLiveTV
2,761 回視聴 - 3 年前
6:43

FLT3 Mutations’ Impact on Prognosis and Treatment in AML

OncLive
3,815 回視聴 - 5 年前
7:30

Immunotherapy in Advanced Melanoma

OncLive
964 回視聴 - 7 年前
1:09

Dr. Budd Discusses Paclitaxel Regimens in Breast Cancer

OncLiveTV
395 回視聴 - 10 年前
3:52

HER2 Positive Gastric Cancer ©OncLiveTV

No Stomach For Cancer
86 回視聴 - 7 年前
7:00

Metastatic Melanoma: The Immunotherapy Approach

OncLive
3,948 回視聴 - 6 年前
5:36

The Value of CT Scans in Chronic Lymphocytic Leukemia

OncLive
2,296 回視聴 - 8 年前
14:45

Management of Adverse Effects in R/R HER2+ mBC

OncLive
1,308 回視聴 - 3 年前
7:47

Adjuvant Therapy for Stage 2/3 Colorectal Cancer

OncLiveTV
11,190 回視聴 - 5 年前
0:54

Dr. Karam on Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Ovarian Cancer

OncLive
1,696 回視聴 - 5 年前
1:39

Dr. Crew on the APHINITY Trial Results in HER2+ Breast Cancer

OncLiveTV
167 回視聴 - 4 年前
0:57

Dr. Cercek on the Need for Treatment Options in KRAS Mutated mCRC

OncLive
606 回視聴 - 4 年前
3:13

Final Thoughts: A Cure in Sight?

OncLive
274 回視聴 - 9 年前
19:20

FDA-approved Therapies for Relapsed/Refractory HER2+ mBC

OncLiveTV
829 回視聴 - 3 年前